PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Total saponins (TSEP) reduced fasting blood glucose and serum insulin levels and alleviated hyperglycemia-associated oxidative stress in rats [PMID: 22212505].
Phaseoloidin suppresses gout inflammation via the NLRP3 inflammasome in mouse and rat models [PMID: 41579591].
Entadamide A-beta-D-glucopyranoside alleviated IMQ-induced psoriasiform dermatitis in mouse models [PMID: 41833762].
Total tannins (TEPT) accelerated wound closure in rats and promoted fibroblast proliferation and migration in vitro [PMID: 28040363].
The n-butanol fraction of ethanol extract inhibited HepG2 cell proliferation by inducing apoptosis [PMID: 24965399].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 29124496 (2018) — Biological activity of Entada phaseoloides and Entada rheedei. · Journal of natural medicines
- 2.PMID: 20931765 (2010) — Sulfur-containing amides from Entada phaseoloides. · Yao xue xue bao = Acta pharmaceutica Sinica
- 3.PMID: 22590279 (2012) — 5,6,7,5'-Tetra-meth-oxy-3',4'-methyl-ene-dioxy-flavone monohydrate. · Acta crystallographica. Section E, Structure reports online
- 4.PMID: 35661414 (2022) — Chromosome-level genome of Entada phaseoloides provides insights into genome evolution and biosynthesis of triterpenoid saponins. · Molecular ecology resources
- 5.PMID: 27742409 (2016) — Entada phaseoloides extract suppresses hepatic gluconeogenesis via activation of the AMPK signaling pathway.